Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

F&P Of New Zealand Reports 70 Percent Profit Increase From Respirators

This article was originally published in PharmAsia News

Executive Summary

New Zealand medical device maker Fisher & Paykel Healthcare says demand for its respiratory humidifier systems and acute care products has been so high the firm expects a 70 percent increase in its net profit this fiscal year. CEO Mike Daniell attributed much of the increase to "substantial orders" by the Group Purchasing Organisation, a hospital group, for U.S. contracts to fill a gap in respirator supplies. The company said it expects a 25 percent revenue growth in the coming year. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel